Drug General Information
| Drug Name |
Avatrombopag
|
||
| Synonyms |
AVATROMBOPAG; 570406-98-3; AKR-501; UNII-3H8GSZ4SQL; 3H8GSZ4SQL; AKR 501; Avatrombopag [USAN:INN]; Doptelet; AS 1670542; Avatrombopag (USAN/INN); GTPL9953; DTXSID30205667; ZINC72190218; AKOS027323962; CS-3397; HY-13463; FT-0728753; D10306; AS1670542
|
||
| Drug Type |
Small molecular drug
|
||
| Company |
Dova Pharmaceuticals
|
||
| Summary |
Avatrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a procedure.
|
||
Drug Chemical Infomation and External Links
|
Formula |
C29H34Cl2N6O3S2
|
| Canonical SMILES |
C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl
|
|
| InChI |
1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38)
|
|
| InChIKey |
OFZJKCQENFPZBH-UHFFFAOYSA-N
|
|
| CAS Number | CAS 570406-98-3 | |
| TTD ID | D0W1DI | |
| DrugBank ID | DB11995 | |
| PubChem Compound ID | 9852519 | |
| PubChem Substance ID |
NA
|
|
| ChEBI ID | NA | |
| ADReCS Drug ID | BADD_D02497 |
Drug-Food (Herb) Interactions
- Drug
- Foods
- Herbs
- Positive
- Negative
- Possible
- Harmful
- No Effect
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |